- Stocks
- Healthcare
- NYSE: CHE

Price (delayed)

$576.91

Market cap

$8.69B

P/E Ratio

35.39

Dividend/share

$1.56

EPS

$16.3

Enterprise value

$8.65B

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of

Chemed's quick ratio has soared by 167% YoY and by 24% from the previous quarter

The debt is down by 44% year-on-year and by 2.8% since the previous quarter

The EPS has increased by 8% from the previous quarter but it has decreased by 6% YoY

The net income has grown by 8% since the previous quarter but it has declined by 7% year-on-year

The price to earnings (P/E) is 25% higher than the 5-year quarterly average of 28.3 and 8% higher than the last 4 quarters average of 32.9

Chemed's gross margin has decreased by 5% YoY

What are the main financial stats of CHE

Market
Valuations
Earnings

Shares outstanding

15.06M

Market cap

$8.69B

Enterprise value

$8.65B

Price to earnings (P/E)

35.39

Price to book (P/B)

8.53

Price to sales (P/S)

3.91

EV/EBIT

26.91

EV/EBITDA

22.68

EV/Sales

3.89

Revenue

$2.23B

EBIT

$321.54M

EBITDA

$381.48M

Free cash flow

$259.4M

Per share
Balance sheet
Liquidity

EPS

$16.3

Free cash flow per share

$17.21

Book value per share

$67.6

Revenue per share

$147.61

TBVPS

$58.66

Total assets

$1.56B

Total liabilities

$542.84M

Debt

$136.96M

Equity

$1.02B

Working capital

$97.32M

Debt to equity

0.13

Current ratio

1.33

Quick ratio

1.15

Net debt/EBITDA

-0.09

Margins
Efficiency
Dividend

EBITDA margin

17.1%

Gross margin

34.5%

Net margin

11%

Operating margin

14%

Return on assets

16.5%

Return on equity

26.8%

Return on invested capital

56.6%

Return on capital employed

25.4%

Return on sales

14.5%

Dividend yield

0.27%

DPS

$1.56

Payout ratio

9.6%

How has the Chemed stock price performed over time

Intraday

0.05%

1 week

1.75%

1 month

-0.95%

1 year

11%

YTD

13.02%

QTD

11.01%

How have Chemed's revenue and profit performed over time

Revenue

$2.23B

Gross profit

$768.33M

Operating income

$310.5M

Net income

$244.58M

Gross margin

34.5%

Net margin

11%

The operating margin has decreased by 17% YoY

Chemed's operating income has decreased by 14% YoY

The net margin is down by 11% year-on-year but it is up by 6% since the previous quarter

The net income has grown by 8% since the previous quarter but it has declined by 7% year-on-year

What is Chemed's growth rate over time

What is Chemed stock price valuation

P/E

35.39

P/B

8.53

P/S

3.91

EV/EBIT

26.91

EV/EBITDA

22.68

EV/Sales

3.89

The price to earnings (P/E) is 25% higher than the 5-year quarterly average of 28.3 and 8% higher than the last 4 quarters average of 32.9

The EPS has increased by 8% from the previous quarter but it has decreased by 6% YoY

Chemed's equity has increased by 41% YoY and by 7% from the previous quarter

The P/B is 9% less than the 5-year quarterly average of 9.4

CHE's P/S is 12% above its 5-year quarterly average of 3.5 and 9% above its last 4 quarters average of 3.6

The revenue rose by 4.5% year-on-year

How efficient is Chemed business performance

The ROE has contracted by 31% YoY

The ROA has declined by 16% year-on-year but it rose by 4.4% since the previous quarter

The ROS has decreased by 11% YoY but it has increased by 3.6% from the previous quarter

The company's return on invested capital rose by 8% QoQ but it fell by 4.4% YoY

What is CHE's dividend history

DPS

$1.56

Dividend yield

0.27%

Payout ratio

9.6%

Recent dividends

How did Chemed financials performed over time

Chemed's total assets is 188% higher than its total liabilities

Chemed's quick ratio has soared by 167% YoY and by 24% from the previous quarter

CHE's current ratio has soared by 99% YoY and by 20% from the previous quarter

The debt is 87% smaller than the equity

CHE's debt to equity has dropped by 62% year-on-year and by 13% since the previous quarter

The debt is down by 44% year-on-year and by 2.8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.